EUVIMEDEUVIMED entdecken
Crossref

The Prognostic Significance Of Inflammation Associated Blood Cell Markers In Metastatic Colorectal Cancer

Ahmet Hüsrev Tekeli, Arife Ulaş

Journal of Bursa Faculty of Medicine · 2024

DOI: 10.61678/bursamed.1395185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bursa Faculty of Medicine, 2024. Verfasst von Ahmet Hüsrev Tekeli und 1 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim is to perform prognostic evaluation with overall survival (OS) and progression-free survival (PFS) in hematological parameter-based groups in patients with metastatic colorectal cancer (mCRC).

Methods

In a single institution, 51 patients were retrospectively analyzed mCRC diagnosed between 2019 and 2022. Pretreatment hematological parameters of patients with mCRC receiving first-line chemotherapy in a single center were examined. The receiver operating characteristic curve was used to predict the tests. Median OS was calculated by the Kaplan-Meier method and compared with the log-rank test. Multivariate analyses were performed using a Cox regression model.

Results

The median OS of the patients included in the study was 27 months (3-88 months) by statistical calculation; the median PFS was 19 months (2-84 months). The median could not be reached. Among the risk factors affecting OS, it was found effective to have a bone metastasis site and a pancreatic metastasis site (p values 0.003 and 0.027, respectively). In the analysis of the risk factors affecting PFS, bone and pancreatic metastases were found to be significant (p values 0.001 and 0.004, respectively). Patients receiving chemotherapy and anti-VEGF therapy have a significantly reduced risk of death of 0.06 times compared to those who do not receive chemotherapy, which indicates that OS is significantly longer in people receiving chemotherapy in question (p=0.020). It was observed that blood cell marker levels were not statistically significant in PFS and OS. Of the 51 patients included in the study, 30 of them were still being followed up, while 21 of them died.

Conclusions

Chemotherapy plus anti-VEGF therapy is a treatment whose effectiveness has been determined in metastatic colorectal cancer. In the future, there is a need for more prospective and large patient group studies on this topic to measure the prognostic value of hematological parameters in metastatic colorectal cancer.

Zitieren

APA

Tekeli, A. H., & Ulaş, A. (2024). The Prognostic Significance Of Inflammation Associated Blood Cell Markers In Metastatic Colorectal Cancer. Journal of Bursa Faculty of Medicine. https://doi.org/10.61678/bursamed.1395185

Vancouver

Tekeli AH, Ulaş A. The Prognostic Significance Of Inflammation Associated Blood Cell Markers In Metastatic Colorectal Cancer. Journal of Bursa Faculty of Medicine. 2024. doi:10.61678/bursamed.1395185

BibTeX
@article{Tekeli2024,
  author = {Tekeli, Ahmet Hüsrev and Ulaş, Arife},
  title = {The Prognostic Significance Of Inflammation Associated Blood Cell Markers In Metastatic Colorectal Cancer},
  journal = {Journal of Bursa Faculty of Medicine},
  year = {2024},
  doi = {10.61678/bursamed.1395185}
}
Kostenlos starten →